Lifestance Health Group, Inc.

88
Strong Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US53228F1012
USD
6.40
-0.18 (-2.74%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Lifestance Health Group, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
12.00
-57.00
-206.00
-232.00
-333.00
-44.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-40.00
-27.00
-33.00
-16.00
2.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
146.00
107.00
-16.00
52.00
9.00
-8.00
Cash Flow from Investing Activities
-36.00
-21.00
-60.00
-139.00
-194.00
-861.00
Cash Flow from Financing Activities
-15.00
-9.00
47.00
47.00
313.00
912.00
Net Cash Inflow / Outflow
94.00
75.00
-29.00
-39.00
129.00
42.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Lifestance Health Group, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
12.363
-313.6
325.00
103.94%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-40.344
-44.088
4.00
8.49%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
146.151
-171.059
317.00
185.44%
Cash Flow from Investing Activities
-36.125
-240.289
204.00
84.97%
Cash Flow from Financing Activities
-15.955
17.775
-32.00
-189.76%
Net Cash Inflow / Outflow
94.071
-393.372
487.00
123.91%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0.201
0.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 36.26% vs 735.28% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
146.15
107.26
36.26%